CN Patent

CN102325545A — 具有神经肽y受体结合化合物的细胞毒性缀合物

Assigned to Ipsen Pharma SAS · Expires 2012-01-18 · 14y expired

What this patent protects

提供了一系列新神经肽Y-细胞毒性缀合物、包含它们的组合物和涉及它们在治疗与表达NPY-Y1受体的细胞异常或不期望的增殖相关的疾病或病症的治疗应用的方法。

USPTO Abstract

提供了一系列新神经肽Y-细胞毒性缀合物、包含它们的组合物和涉及它们在治疗与表达NPY-Y1受体的细胞异常或不期望的增殖相关的疾病或病症的治疗应用的方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN102325545A
Jurisdiction
CN
Classification
—
Expires
2012-01-18
Drug substance claim
No
Drug product claim
No
Assignee
Ipsen Pharma SAS
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.